{"content":"<li class=\"n-box-item date-title\" data-end=\"1520485199\" data-start=\"1520398800\" data-txt=\"Monday, December 23, 2019\">Wednesday, March  7, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3337387\" data-ts=\"1520469149\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARES\" target=\"_blank\">ARES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337387-ares-management-prices-secondary-shares-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ares Management prices secondary shares at $22 each</a></h4><ul>   <li>Ares Management (NYSE:<a href='https://seekingalpha.com/symbol/ARES' title='Ares Management Corporation'>ARES</a>) has <a href=\"https://seekingalpha.com/pr/17095990-ares-management-l-p-announces-pricing-offering-common-shares\" target=\"_blank\">priced a secondary offering</a> of shares at $22 each.</li>    <li>The company is offering 5M shares for sale, and a strategic investor is selling 10M shares (along with granting an option to buy up to 2.25M more).</li>    <li>Ares will use proceeds from its issuance for general purposes.</li>    <li>The company and its directors and executives, along with the selling shareholder, have agreed to a customary lock-up agreement with underwriters.</li>    <li>Shares <font color='red'>fell 2.4%</font> during market hours today to close at $22.30; they're <font color='red'>down 0.7%</font> postmarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337387\" data-linked=\"Ares Management prices secondary shares at $22 each\" data-tweet=\"$ARES - Ares Management prices secondary shares at $22 each https://seekingalpha.com/news/3337387-ares-management-prices-secondary-shares-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3337387-ares-management-prices-secondary-shares-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337385\" data-ts=\"1520468434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337385-guidewireminus-2_4-on-offerings-of-200m-in-equity-300m-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire -2.4% on offerings of $200M in equity, $300M in debt</a></h4><ul>   <li>Guidewire Software (NYSE:<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a>) is <font color='red'>2.4% lower</font> after hours on news that it's <a href=\"https://seekingalpha.com/pr/17095819-guidewire-software-inc-announces-proposed-public-offerings-200-million-common-stock-300\" target=\"_blank\">launching offerings</a> of $200M in common stock and $300M in senior debt.</li>    <li>The senior debt comes in convertible notes due 2025.</li>    <li>Underwriters of the share offering will have a 30-day greenshoe option to buy up to $30M in additional shares at the offering price; underwriters of the notes will have a 30-day option to buy up to $45M in additional notes.</li>    <li>Guidewire expects to enter capped call transactions with note underwriters to offset potential dilution from any conversion of notes.</li>    <li>Shares had <font color='green'>risen 7%</font> during the regular session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337385\" data-linked=\"Guidewire -2.4% on offerings of $200M in equity, $300M in debt\" data-tweet=\"$GWRE - Guidewire -2.4% on offerings of $200M in equity, $300M in debt https://seekingalpha.com/news/3337385-guidewireminus-2_4-on-offerings-of-200m-in-equity-300m-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3337385-guidewireminus-2_4-on-offerings-of-200m-in-equity-300m-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337372\" data-ts=\"1520463705\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337372-comtechplus-7-after-beat-and-raise-in-fiscal-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech +7% after beat and raise in fiscal Q2</a></h4><ul>   <li>Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) is among top postmarket gainers, <font color='green'>up 7%</font> after its <a href=\"https://seekingalpha.com/news/3337298-comtech-telecommunications-beats-0_15-beats-revenue\" target=\"_blank\">fiscal Q2</a> showed a surprise profit and raised guidance for 2018.</li>    <li>Net sales declined slightly to $133.7M.</li>    <li>Bookings came to $210.6M and book-to-bill ratio was 1.57. Backlog of $567.3M neared a record high, and doesn't account for the unfunded parts of multi-year contracts.</li>    <li>For the fiscal year, it's boosting revenue expectations to $570M-$585M from $550M-$575M (and above consensus for $561.6M). It's raising its EBITDA target to $72M-$76M from $69M-$73M (and above an expected $70.1M), and boosting guidance for GAAP EPS to $1.08-$1.23.</li>    <li><a href=\"http://www.comtechtel.com\" target=\"_blank\">Conference call</a> to come tomorrow at 8:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17095842-comtech-telecommunications-corp-announces-results-fiscal-2018-second-quarter-updates-fiscal\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337372\" data-linked=\"Comtech +7% after beat and raise in fiscal Q2\" data-tweet=\"$CMTL - Comtech +7% after beat and raise in fiscal Q2 https://seekingalpha.com/news/3337372-comtechplus-7-after-beat-and-raise-in-fiscal-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3337372-comtechplus-7-after-beat-and-raise-in-fiscal-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337366\" data-ts=\"1520462186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337366-after-hours-gainers-losers-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (3/7/2018)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a> <font color='green'>+9.7%</font>. <a href='https://seekingalpha.com/symbol/CTMX' title='CytomX Therapeutics'>CTMX</a> <font color='green'>+7.7%</font>. <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='green'>+6.6%</font>. <a href='https://seekingalpha.com/symbol/CLDX' title='Celldex Therapeutics, Inc'>CLDX</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color='green'>+4.8%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/ZAGG' title='ZAGG Inc'>ZAGG</a> <font color='red'>-7.7%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a> <font color='red'>-2.3%</font>. <a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a> <font color='red'>-2.0%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='red'>-2.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337366\" data-linked=\"After Hours Gainers / Losers (3/7/2018)\" data-tweet=\"$RCII $RCII $CTMX - After Hours Gainers / Losers (3/7/2018) https://seekingalpha.com/news/3337366-after-hours-gainers-losers-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337366-after-hours-gainers-losers-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337363\" data-ts=\"1520461470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RCII\" target=\"_blank\">RCII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337363-rent-centerplus-10-after-announcing-layoffs-evaluating-potential-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rent-A-Center +10% after announcing layoffs, evaluating potential sale</a></h4><ul>     <li>Rent-A-Center (NASDAQ:<a href='https://seekingalpha.com/symbol/RCII' title='Rent-A-Center Inc.'>RCII</a>) <font color='green'>+9.8%</font> after-hours on news it <a href=\"https://seekingalpha.com/pr/17095865-rent-center-provides-business-updates\" target=\"_blank\">will cut 250 jobs</a>, or ~25% of its corporate workforce in Plano, Tex., as part of a plan to generate $28M in annual run-rate cost savings, including ~$20M realized this year.</li><li>RCII also reiterates that it is continuing to review strategic and financial alternatives to maximize stockholder value,       including evaluating a sale of the company, for which it says it has received       proposals from interested bidders.</li><li>RCII expects $3M in severance charges and one-time costs related to the workforce reductions in Q1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337363\" data-linked=\"Rent-A-Center +10% after announcing layoffs, evaluating potential sale\" data-tweet=\"$RCII - Rent-A-Center +10% after announcing layoffs, evaluating potential sale https://seekingalpha.com/news/3337363-rent-centerplus-10-after-announcing-layoffs-evaluating-potential-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3337363-rent-centerplus-10-after-announcing-layoffs-evaluating-potential-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337349\" data-ts=\"1520460345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVN\" target=\"_blank\">DVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337349-devon-energy-to-sell-part-of-barnett-shale-assets-for-533m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Devon Energy to sell part of Barnett Shale assets for $533M</a></h4><ul>     <li>Devon Energy (NYSE:<a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a>) <a href=\"https://seekingalpha.com/pr/17095796-devon-energy-announces-553-million-sale-johnson-county-assets\" target=\"_blank\">agrees to sell</a> the southern portion of its Barnett Shale position to an undisclosed buyer for $533M; shares <font color='green'>+1.8%</font> after-hours as it also <a href=\"https://seekingalpha.com/news/3337280-devon-energy-declares-0_08-dividend\" target=\"_blank\">raises its dividend by a third</a> and announces a $1B stock buyback plan.</li>     <li>&ldquo;Combined with other recent asset sales, divestiture proceeds associated with our 2020 Vision have now reached $1B,&rdquo; says DVN&nbsp;President and CEO Dave Hager.</li>     <li>DVN says current net production from the southern Barnett divestiture assets averages 200M cfe/day, while its remaining position produces 680M cfe/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337349\" data-linked=\"Devon Energy to sell part of Barnett Shale assets for $533M\" data-tweet=\"$DVN - Devon Energy to sell part of Barnett Shale assets for $533M https://seekingalpha.com/news/3337349-devon-energy-to-sell-part-of-barnett-shale-assets-for-533m?source=tweet\" data-url=\"https://seekingalpha.com/news/3337349-devon-energy-to-sell-part-of-barnett-shale-assets-for-533m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337342\" data-ts=\"1520459875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337342-inseegoplus-3_1-moves-to-operating-profit-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego +3.1% as it moves to operating profit in Q4</a></h4><ul>   <li>Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color='green'>up 3.1%</font> in postmarket trade following mixed <a href=\"https://seekingalpha.com/news/3337273-inseego-misses-0_06-misses-revenue\" target=\"_blank\">Q4 earnings</a> where revenues declined and missed but the company logged a smaller loss than expected.</li>    <li>It's swung to operating profit (GAAP basis) ahead of plan, it says, with $0.8M. EBITDA came to $2.8M vs. an expected $2.3M.</li>    <li>Operating expenses have declined more than $30M annualized since Q1 2017.</li>    <li>Revenue breakout: Hardware, $31.8M (down 16.3%); SaaS, Sofware and Services, $14.8M (down 1.2%).</li>    <li>Cash and equivalents were $21.3M at quarter's end.</li>    <li>For Q1, it's guiding to revenue of $45M-$50M (light of consensus for $52.6M) and EBITDA of $3M-$3.5M (vs. expectations for $3.9M). Enterprise SaaS solutions should provide $17M-$19M in revenue, with IoT and Mobile Solutions providing $28M-$31M, it says.</li>    <li><a href=\"http://investor.inseego.com\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17095774-inseego-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337342\" data-linked=\"Inseego +3.1% as it moves to operating profit in Q4\" data-tweet=\"$INSG - Inseego +3.1% as it moves to operating profit in Q4 https://seekingalpha.com/news/3337342-inseegoplus-3_1-moves-to-operating-profit-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3337342-inseegoplus-3_1-moves-to-operating-profit-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337321\" data-ts=\"1520458729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337321-comparable-sales-strong-costco\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comparable sales strong at Costco</a></h4><ul><li>Comparable sales increased 8.4% at Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) in <a href=\"https://seekingalpha.com/pr/17095823-costco-wholesale-corporation-reports-second-quarter-year-date-operating-results-fiscal-2018\" target=\"_blank\">FQ2</a> to help lift the company to 11% total sales growth for the quarter.</li><li>U.S. comparable sales were up 7.1% during the period, while international sales rose 15.7% Y/Y.</li><li>E-commerce sales jumped 28.5%.</li><li>Membership fee revenue rose to $716M vs. $636M a year ago.</li><li>COST&nbsp;<font color='red'>-0.89%</font>&nbsp;AH to $185.69.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337296-costco-wholesale-misses-0_04-beats-revenue\" target=\"_blank\">Costco Wholesale misses by $0.04, beats on revenue</a> (March 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337321\" data-linked=\"Comparable sales strong at Costco\" data-tweet=\"$COST - Comparable sales strong at Costco https://seekingalpha.com/news/3337321-comparable-sales-strong-costco?source=tweet\" data-url=\"https://seekingalpha.com/news/3337321-comparable-sales-strong-costco\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337314\" data-ts=\"1520458478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLS\" target=\"_blank\">RGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337314-regulus-therapeutics-beats-0_02-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulus Therapeutics beats by $0.02, misses on revenue</a></h4><ul><li>Regulus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a>): Q4 EPS of -$0.14 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $0.02M (flat Y/Y) <font color='red'>misses by $0.72M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17095793-regulus-reports-fourth-quarter-year-end-2017-financial-results-pipeline-update\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337314\" data-linked=\"Regulus Therapeutics beats by $0.02, misses on revenue\" data-tweet=\"$RGLS - Regulus Therapeutics beats by $0.02, misses on revenue https://seekingalpha.com/news/3337314-regulus-therapeutics-beats-0_02-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337314-regulus-therapeutics-beats-0_02-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337307\" data-ts=\"1520457968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSLR\" target=\"_blank\">VSLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337307-vivint-solarminus-3-after-larger-expected-q4-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivint Solar -3% after larger than expected Q4 loss</a></h4><ul>     <li>Vivint Solar (NYSE:<a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a>)&nbsp;<font color='red'>-3.3%</font> after-hours as it reports a larger than expected <a href=\"https://seekingalpha.com/news/3337266-vivint-solar-misses-0_11-misses-revenue\" target=\"_blank\">Q4 loss</a> despite a 60% Y/Y revenue increase.</li>     <li>During Q4, VSLR says it booked ~55 MWs and installed 45 MWs for the quarter; cost per watt was $2.95, up from $2.94 in Q3 but down from $3.08 in year-ago quarter.</li>     <li>For Q1, VSLR expects 40 MWs installed at a cost per watt of $3.15-$3.20.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337307\" data-linked=\"Vivint Solar -3% after larger than expected Q4 loss\" data-tweet=\"$VSLR - Vivint Solar -3% after larger than expected Q4 loss https://seekingalpha.com/news/3337307-vivint-solarminus-3-after-larger-expected-q4-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3337307-vivint-solarminus-3-after-larger-expected-q4-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337298\" data-ts=\"1520457627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337298-comtech-telecommunications-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecommunications beats by $0.15, beats on revenue</a></h4><ul><li>Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>): Q2 EPS of $0.07 <font color='green'>beats by $0.15</font>.</li><li>Revenue of $133.7M (-3.8% Y/Y) <font color='green'>beats by $9.05M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/17095842-comtech-telecommunications-corp-announces-results-fiscal-2018-second-quarter-updates-fiscal'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337298\" data-linked=\"Comtech Telecommunications beats by $0.15, beats on revenue\" data-tweet=\"$CMTL - Comtech Telecommunications beats by $0.15, beats on revenue https://seekingalpha.com/news/3337298-comtech-telecommunications-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337298-comtech-telecommunications-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337296\" data-ts=\"1520457566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337296-costco-wholesale-misses-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco Wholesale misses by $0.04, beats on revenue</a></h4><ul><li>Costco Wholesale (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>): Q2 EPS of $1.42 <font color='red'>misses by $0.04</font>.</li><li>Revenue of $33B (+10.8% Y/Y) <font color='green'>beats by $280M</font>.</li><li>Shares <font color='green'>+2.6%</font>.</li><li><a href='https://seekingalpha.com/pr/17095823-costco-wholesale-corporation-reports-second-quarter-year-date-operating-results-fiscal-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337296\" data-linked=\"Costco Wholesale misses by $0.04, beats on revenue\" data-tweet=\"$COST - Costco Wholesale misses by $0.04, beats on revenue https://seekingalpha.com/news/3337296-costco-wholesale-misses-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337296-costco-wholesale-misses-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337293\" data-ts=\"1520457481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRVS\" target=\"_blank\">CRVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337293-corvus-pharmaceuticals-launches-50m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Corvus Pharmaceuticals launches $50M stock offering</a></h4><ul><li>Corvus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRVS' title='Corvus Pharmaceuticals'>CRVS</a>) <a href=\"https://seekingalpha.com/pr/17095783-corvus-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a $50M public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337293\" data-linked=\"Corvus Pharmaceuticals launches $50M stock offering\" data-tweet=\"$CRVS - Corvus Pharmaceuticals launches $50M stock offering https://seekingalpha.com/news/3337293-corvus-pharmaceuticals-launches-50m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3337293-corvus-pharmaceuticals-launches-50m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337290\" data-ts=\"1520457374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CKPT\" target=\"_blank\">CKPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337290-checkpoint-therapeutics-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Checkpoint Therapeutics readies stock offering</a></h4><ul><li>Checkpoint Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CKPT' title='CHECKPOINT THERAPEUTICS'>CKPT</a>) <a href=\"https://seekingalpha.com/pr/17095778-checkpoint-therapeutics-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337290\" data-linked=\"Checkpoint Therapeutics readies stock offering\" data-tweet=\"$CKPT - Checkpoint Therapeutics readies stock offering https://seekingalpha.com/news/3337290-checkpoint-therapeutics-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3337290-checkpoint-therapeutics-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337282\" data-ts=\"1520457210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYES\" target=\"_blank\">EYES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337282-second-sight-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Second Sight EPS in-line, beats on revenue</a></h4><ul><li>Second Sight (NASDAQ:<a href='https://seekingalpha.com/symbol/EYES' title='Second Sight Medical Products'>EYES</a>): Q4 EPS of -$0.14 in-line.</li><li>Revenue of $3.1M (+330.6% Y/Y) <font color='green'>beats by $1.49M</font>.</li><li>Shares <font color='green'>+8.11%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17095751-second-sight-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337282\" data-linked=\"Second Sight EPS in-line, beats on revenue\" data-tweet=\"$EYES - Second Sight EPS in-line, beats on revenue https://seekingalpha.com/news/3337282-second-sight-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337282-second-sight-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337257\" data-ts=\"1520456250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHM\" target=\"_blank\">ATHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337257-autohomeminus-2-slack-guidance-overshadows-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autohome -2% as slack guidance overshadows Q4 beat</a></h4><ul>   <li>Autohome (NYSE:<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a>) is <font color='red'>2% lower</font> today after a <a href=\"https://seekingalpha.com/news/3337012-autohome-beats-0_31-beats-revenue\" target=\"_blank\">solid beat</a> on top and bottom lines in Q4 that contained some below-consensus guidance for Q1.</li>    <li>The drop-off in its online marketplace revenues more than offset gains in media services (of 32%) and leads generation (up 29%); revenues overall fell 15%.</li>    <li>But net income attributable to Autohome rose 94% Y/Y to 730.4M yuan (about $112.3M).</li>    <li>Revenue breakout: Media services, 968.5M yuan (up 32% and about $148.9M in dollar terms); leads generation, 717.5M yuan (up 29% and $110.3M); online marketplace, 65.4M yuan (down 91% and $10.1M).</li>    <li>Cash from operations was 1.322B yuan (about $203.2M), up 67% in renminbi terms.</li>    <li>It's guiding to Q1 revenues of 1.22B-1.25B yuan (about $187.5M-$192.1M, below an expected $204.5M).</li>    <li><a href=\"https://seekingalpha.com/pr/17094514-autohome-inc-announces-unaudited-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337257\" data-linked=\"Autohome -2% as slack guidance overshadows Q4 beat\" data-tweet=\"$ATHM - Autohome -2% as slack guidance overshadows Q4 beat https://seekingalpha.com/news/3337257-autohomeminus-2-slack-guidance-overshadows-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3337257-autohomeminus-2-slack-guidance-overshadows-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337254\" data-ts=\"1520455045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAS\" target=\"_blank\">BAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337254-basic-energy-pulls-300m-offering-of-senior-secured-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Basic Energy pulls $300M offering of senior secured notes</a></h4><ul>     <li>Basic Energy Services (<a href='https://seekingalpha.com/symbol/BAS' title='Basic Energy Services, Inc.'>BAS</a> <font color='red'>-7.1%</font>) sinks after saying it <a href=\"https://seekingalpha.com/pr/17095533-basic-energy-services-announces-withdrawal-proposed-senior-secured-notes-offering\" target=\"_blank\">will not proceed</a> with its previously announced offering of $300M of senior secured notes.</li>     <li>BAS says it decided that current rate and structure available in the market lacked the flexibility to be sufficiently attractive to move forward.</li>     <li>BAS says it is continuing to seek a new five-year revolving credit facility of as much as $150M secured by accounts receivable, inventory and certain related assets to replace the existing $120M asset-based credit facility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337254\" data-linked=\"Basic Energy pulls $300M offering of senior secured notes\" data-tweet=\"$BAS - Basic Energy pulls $300M offering of senior secured notes https://seekingalpha.com/news/3337254-basic-energy-pulls-300m-offering-of-senior-secured-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3337254-basic-energy-pulls-300m-offering-of-senior-secured-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337253\" data-ts=\"1520454934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337253-xpresspa-wtc-services-available-through-classpass\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XpresSpa WTC services available through ClassPass</a></h4><ul>   <li>XpresSpa (<a href=\"http://seekingalpha.com/symbol/XSPA\" target=\"_blank\">XSPA</a> <font color='green'>+5.1%</font>) is expanding its scope at its World Trade Center location by offering <a href=\"https://seekingalpha.com/pr/17094936-xpresspa-partners-classpass-world-trade-center-location\" target=\"_blank\">services through ClassPass</a>.</li>    <li>ClassPass offers members subscription access to a variety of fitness experiences and has 8,500 partners worldwide.</li>    <li>XpresSpa will offer select massage service as well as its NormaTec compression therapy in the partnership.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337253\" data-linked=\"XpresSpa WTC services available through ClassPass\" data-tweet=\"$XSPA - XpresSpa WTC services available through ClassPass https://seekingalpha.com/news/3337253-xpresspa-wtc-services-available-through-classpass?source=tweet\" data-url=\"https://seekingalpha.com/news/3337253-xpresspa-wtc-services-available-through-classpass\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337251\" data-ts=\"1520454720\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337251-frontier-offering-1_6b-in-debt-in-private-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Frontier offering $1.6B in debt in private deal</a></h4><ul>   <li>Frontier Communications (<a href=\"http://seekingalpha.com/symbol/FTR\" target=\"_blank\">FTR</a> <font color='green'>+1.6%</font>) is <a href=\"https://seekingalpha.com/pr/17095529-frontier-communications-announces-1_6-billion-second-lien-secured-notes-offering\" target=\"_blank\">offering $1.6B</a> in second-lien secured notes in a private transaction.</li>    <li>The offering, tied to the company's <a href=\"https://seekingalpha.com/news/3336970-frontier-launches-cash-tender-1_6b-debt\" target=\"_blank\">tender offers</a> amounting to the same aggregate size, is for debt due 2026.</li>    <li>Those tender offers are planned to expire April 2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337251\" data-linked=\"Frontier offering $1.6B in debt in private deal\" data-tweet=\"$FTR - Frontier offering $1.6B in debt in private deal https://seekingalpha.com/news/3337251-frontier-offering-1_6b-in-debt-in-private-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3337251-frontier-offering-1_6b-in-debt-in-private-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337249\" data-ts=\"1520453522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KR\" target=\"_blank\">KR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337249-anxiety-builds-over-kroger-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anxiety builds over Kroger earnings</a></h4><ul>     <li>Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='red'>-4.9%</font>) is sharply lower ahead of the company's earnings report due out out tomorrow morning.</li>     <li>Some recent stumbles in the retail sector with big names appear to have investors edgy. \"It is possible that the cumulative effect of the recent commentary by WMT, TGT, and DLTR are causing some anxiety before KR earnings,\" Pivotal analyst Ajay Jain tells Bloomberg.</li>     <li>Consensus estimates on Kroger are for revenue of $30.8B, identical sales growth of 1.4% and EPS of $0.63.</li>     <li>Sector watch: Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a> <font color='red'>-4%</font>), SuperValue (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='red'>-4.3%</font>), Sprouts Farmers Market (<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='red'>-2.5%</font>), Natural Grocers By Vitamin Cottage (<a href='https://seekingalpha.com/symbol/NGVC' title='Natural Grocers'>NGVC</a> <font color='red'>-3.9%</font>) and Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='red'>-1.3%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337249\" data-linked=\"Anxiety builds over Kroger earnings\" data-tweet=\"$KR $KR $SFS - Anxiety builds over Kroger earnings https://seekingalpha.com/news/3337249-anxiety-builds-over-kroger-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3337249-anxiety-builds-over-kroger-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337245\" data-ts=\"1520452517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337245-technology-top-gainers-losers-of-2_55-pm-3-7-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (3/7/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ALTR' title='Altair Engineering, Inc.  Cl A'>ALTR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MEET' title='The Meet Group, Inc.'>MEET</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TLND' title='Talend SA'>TLND</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337245\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (3/7/18)\" data-tweet=\"$ADSK $ADSK $FORM - Technology - Top Gainers / Losers as of 2.55 pm (3/7/18) https://seekingalpha.com/news/3337245-technology-top-gainers-losers-of-2_55-pm-3-7-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3337245-technology-top-gainers-losers-of-2_55-pm-3-7-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337242\" data-ts=\"1520451307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337242-snap-pares-gains-on-report-planning-biggest-layoff-yet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap pares gains on report it&#39;s planning biggest layoff yet</a></h4><ul>   <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='green'>+0.7%</font>) is paring gains after a report from Cheddar that the company is <a href=\"https://cheddar.com/videos/exclusive-snap-plans-biggest-round-of-layoffs-yet\" target=\"_blank\">planning its biggest layoff to date</a>.</li>    <li>An internal announcement will come within a week and focus on the engineering department, though it was affect less than 10% of that department, one source told Cheddar.</li>    <li>The company reported having 3,069 employees at the end of 2017. It had laid off a couple dozen last year followed by about two dozen more cuts in January.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337242\" data-linked=\"Snap pares gains on report it&#39;s planning biggest layoff yet\" data-tweet=\"$SNAP - Snap pares gains on report it&#39;s planning biggest layoff yet https://seekingalpha.com/news/3337242-snap-pares-gains-on-report-planning-biggest-layoff-yet?source=tweet\" data-url=\"https://seekingalpha.com/news/3337242-snap-pares-gains-on-report-planning-biggest-layoff-yet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337238\" data-ts=\"1520450518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337238-exxonminus-3-after-unveiling-big-spending-boost-to-lift-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exxon -3% after unveiling big spending boost to lift production</a></h4><ul>     <li>Exxon Mobil's (<a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-3%</font>) aggressive plans to <a href=\"https://seekingalpha.com/news/3337134-exxon-seeks-double-earnings-cash-flow-2025\" target=\"_blank\">triple production by 2025</a> comes at a cost: $24B spending on capital projects this year, $28B next year and an average of $30B during 2023-25.</li>     <li>&ldquo;<a href=\"https://www.reuters.com/article/us-exxon-mobil-meeting/exxon-unveils-bold-capital-spending-plan-to-boost-profit-shares-drop-idUSKCN1GJ1TP\" target=\"_blank\">Capex is the price you pay for cash flow</a>,&rdquo; says Chairman and CEO&nbsp;Darren Woods, who notes every $1 in capex by XOM in the past decade has generated $1.20 in operating cash flow.</li>     <li>The higher spending &ldquo;highlights that there are no easy fixes to rejuvenate Exxon&rsquo;s portfolio, and it is likely to take time for this investment to flow through into higher earnings, cash flow and returns,&rdquo; says RBC Capital analyst Biraj Borkhataria.</li>     <li>&ldquo;Please disclose more and meet us more. We would be greatly appreciative,&rdquo; Wolfe Research's Paul Sankey tells Woods at today's analyst meeting; Woods does not commit to participating on XOM's earnings conference call, but says he has been meeting more with investors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337238\" data-linked=\"Exxon -3% after unveiling big spending boost to lift production\" data-tweet=\"$XOM - Exxon -3% after unveiling big spending boost to lift production https://seekingalpha.com/news/3337238-exxonminus-3-after-unveiling-big-spending-boost-to-lift-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3337238-exxonminus-3-after-unveiling-big-spending-boost-to-lift-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337233\" data-ts=\"1520449710\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337233-sinclairs-planned-new-york-chicago-station-sales-advance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair&#39;s planned New York, Chicago station sales advance</a></h4><ul>   <li>A controversial plan by Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='red'>-1.8%</font>) to sell (but still run) stations in New York and Chicago to clear ownership-limit hurdles to its takeover of Tribune Media (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='red'>-0.4%</font>) is <a href=\"https://www.bloomberg.com/news/articles/2018-03-07/controversial-sinclair-station-sales-in-nyc-chicago-advance\" target=\"_blank\">moving forward</a>.</li>    <li>In revised FCC filings, Sinclair says it's executed sales deals for WPIX in New York -- for $15M to a company controlled by the estate of the mother of Executive Chairman David Smith. And WGN in Chicago is set to go for $60M to a Maryland executive whose car dealership is controlled by Smith.</li>    <li>Sinclair would also retain a buyback option in the deals.</li>    <li>The company's also sought temporary authority to hold leading stations in Greensboro, N.C., and Indianapolis as it waits to hear whether it can keep them.</li>    <li>Sinclair has 193 stations and would get an additional 42 stations in the Tribune deal; Nexstar (<a href=\"http://seekingalpha.com/symbol/NXST\" target=\"_blank\">NXST</a> <font color='red'>-1.5%</font>) has 170 stations, and Gray Television (<a href=\"http://seekingalpha.com/symbol/GTN\" target=\"_blank\">GTN</a> <font color='red'>-1.8%</font>) more than 100.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3333351-sinclair-broadcast-sell-keep-running-ny-chicago-stations\" target=\"_blank\">Sinclair Broadcast to sell (but keep running) NY, Chicago stations</a> (Feb. 22 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337233\" data-linked=\"Sinclair&#39;s planned New York, Chicago station sales advance\" data-tweet=\"$SBGI $SBGI $TRCO - Sinclair&#39;s planned New York, Chicago station sales advance https://seekingalpha.com/news/3337233-sinclairs-planned-new-york-chicago-station-sales-advance?source=tweet\" data-url=\"https://seekingalpha.com/news/3337233-sinclairs-planned-new-york-chicago-station-sales-advance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337230\" data-ts=\"1520449410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMTX\" target=\"_blank\">AMTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337230-energy-materials-top-gainers-losers-of-2-00-pm-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/7/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AMTX' title='Aemetis, Inc.'>AMTX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/TREC' title='Trecora Resources'>TREC</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/DWSN' title='Dawson Geophysical Company'>DWSN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AAV-OLD' title='Advantage Oil & Gas Ltd.'>AAV-OLD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337230\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/7/2018)\" data-tweet=\"$AMTX $AMTX $TREC - Energy/Materials - Top Gainers / Losers as of 2:00 pm (3/7/2018) https://seekingalpha.com/news/3337230-energy-materials-top-gainers-losers-of-2-00-pm-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337230-energy-materials-top-gainers-losers-of-2-00-pm-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337224\" data-ts=\"1520446970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337224-veon-shores-up-spectrum-position-in-ukraine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veon shores up spectrum position in Ukraine</a></h4><ul>   <li>Veon (<a href=\"http://seekingalpha.com/symbol/VEON\" target=\"_blank\">VEON</a> <font color='red'>-4.9%</font>) has <a href=\"https://seekingalpha.com/pr/17094501-veon-acquires-1800-mhz-spectrum-ukraine\" target=\"_blank\">bought spectrum</a> in the 1800-MHz band in Ukraine.</li>    <li>Its local business, Kyivstar, bought 25 MHz paired for 1.325B hryvnia (about $49M) and two lots of 5 MHz paired at 1.512B hryvnia (about $56M).</li>    <li>Those airwaves are suitable for 4G LTE, the company says; with the biggest contiguous spectrum in 1800 MHz and 2600 MHz, it expects to boost geographical coverage of its high-speed data network.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337224\" data-linked=\"Veon shores up spectrum position in Ukraine\" data-tweet=\"$VEON - Veon shores up spectrum position in Ukraine https://seekingalpha.com/news/3337224-veon-shores-up-spectrum-position-in-ukraine?source=tweet\" data-url=\"https://seekingalpha.com/news/3337224-veon-shores-up-spectrum-position-in-ukraine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337219\" data-ts=\"1520446369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCI\" target=\"_blank\">HCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337219-financials-top-gainers-losers-of-1-10-pm-03-07-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:10 PM (03/07/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HCI' title='HCI Group, Inc.'>HCI</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/IAF' title='Aberdeen Australia Equity Fund'>IAF</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337219\" data-linked=\"Financials - Top Gainers / Losers as of 1:10 PM (03/07/2018)\" data-tweet=\"$HCI $HCI $WHLR - Financials - Top Gainers / Losers as of 1:10 PM (03/07/2018) https://seekingalpha.com/news/3337219-financials-top-gainers-losers-of-1-10-pm-03-07-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337219-financials-top-gainers-losers-of-1-10-pm-03-07-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337213\" data-ts=\"1520444970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESPR\" target=\"_blank\">ESPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337213-esperion-down-6-after-release-of-late-stage-data-on-high-cholesterol-med-bempedoic-acid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Esperion down 6% after release of late-stage data on high cholesterol med bempedoic acid</a></h4><ul><li>Esperion (<a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a> <font color='red'>-6.2%</font>) is in the red on almost triple normal, failing to hold onto its modest premarket gain after <a href=\"https://seekingalpha.com/pr/17094690-esperion-announces-positive-top-line-results-first-pivotal-phase-3-study-bempedoic-acid\" target=\"_blank\">announcing </a>positive Phase 3 results for bempedoic acid in statin-intolerant high-risk cardiovascular disease patients with elevated levels of \"bad\" cholesterol (LDL-C).</li><li>Investors appear disappointed with the 28% lowering of LDL-C versus placebo after 12 weeks of treatment, less than Amgen's (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-2%</font>) <a href=\"https://www.repathahcp.com/?&amp;WT.z_co=A&amp;WT.z_in=DYS&amp;WT.z_ch=PDS&amp;WT.z_st=Site1&amp;WT.z_mt=EM&amp;WT.z_pdskw=repatha_package_insert&amp;Wt.z_ag=prescribing_information_brand_exact&amp;Wt.z_se=G&amp;Wt.srch=1&amp;WT.z_prm=AG0000022000&amp;WT.mc_id=A_DYS_PDS_G_AG0000022000_&amp;Wt.srch=1&amp;WT.z_prm=_EM_repatha_package_insert_prescribing_information_brand_exact&amp;gclid=Cj0KCQiAuP7UBRDiARIsAFpxiRI4oS19Hfdm5cHGq2AUtwBPVfbDS_rfIKDMA_BZZ76hP4FjbmfrANUaAoT-EALw_wcB&amp;gclsrc=aw.ds&amp;dclid=COTeid_d2tkCFRGwTwodogMLeQ\" target=\"_blank\">Repatha</a> (evolocumab) which trimmed LDL-C by 57% in 12 weeks, albeit by monthly injection (MENDEL-2 study). Regeneron (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-1.1%</font>) and Sanofi's (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='green'>+0.1%</font>) <a href=\"https://www.praluent.com/\" target=\"_blank\">Praluent </a>(alirocumab) was close behind with a 48% drop (pooled data from Studies 3 and 4).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337087-esperions-high-cholesterol-med-bempedoic-acid-successful-late-stage-study\" target=\"_blank\">Esperion's high cholesterol med bempedoic acid successful in late-stage study</a> (March 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337213\" data-linked=\"Esperion down 6% after release of late-stage data on high cholesterol med bempedoic acid\" data-tweet=\"$ESPR $ESPR $AMGN - Esperion down 6% after release of late-stage data on high cholesterol med bempedoic acid https://seekingalpha.com/news/3337213-esperion-down-6-after-release-of-late-stage-data-on-high-cholesterol-med-bempedoic-acid?source=tweet\" data-url=\"https://seekingalpha.com/news/3337213-esperion-down-6-after-release-of-late-stage-data-on-high-cholesterol-med-bempedoic-acid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337212\" data-ts=\"1520444521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337212-midday-gainers-losers-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (3/7/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/MED' title='Medifast, Inc.'>MED</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HCI' title='HCI Group, Inc.'>HCI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/RADA' title='Rada Electronics Industries Limited'>RADA</a> <font color='green'>+14%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NTN' title='NTN Buzztime, Inc'>NTN</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AVAV' title='AeroVironment, Inc.'>AVAV</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RAVN' title='Raven Industries, Inc.'>RAVN</a>&nbsp;<font color='red'>-11%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337212\" data-linked=\"Midday Gainers / Losers (3/7/2018)\" data-tweet=\"$OGEN $OGEN $MED - Midday Gainers / Losers (3/7/2018) https://seekingalpha.com/news/3337212-midday-gainers-losers-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337212-midday-gainers-losers-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337211\" data-ts=\"1520444469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTW\" target=\"_blank\">MTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337211-icahn-says-suggestion-of-insider-trading-on-manitowoc-categorically-untrue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn says suggestion of insider trading on Manitowoc &#39;categorically untrue&#39;</a></h4><ul>     <li>Carl Icahn issues a statement <a href=\"https://www.cnbc.com/2018/03/07/carl-icahn-any-suggestion-of-insider-trading-on-manitowoc-is-categorically-untrue.html\" target=\"_blank\">rejecting that he had prior knowledge</a> of the Trump administration&rsquo;s announcement of new tariffs on steel imports.</li>     <li>Reports had noted that Icahn-controlled entities <a href=\"https://seekingalpha.com/news/3336239-bloomberg-icahn-sold-manitowoc-stake-ahead-tariff-news\" target=\"_blank\">sold more than a third of their stakes</a> in crane maker Manitowoc (<a href='https://seekingalpha.com/symbol/MTW' title='Manitowoc Company, Inc.'>MTW</a> <font color='red'>-2.5%</font>) during Feb. 12-22, selling down Icahn's previous 7.5% stake in the company to 4.85%.</li>     <li>\"Recent media speculation regarding our sale of Manitowoc stock calls for a response,\"&nbsp;Icahn says. \"We state for the record: Any suggestion that we had prior knowledge of the Trump administration's announcement of new tariffs on steel imports is categorically untrue. We reduced our position in Manitowoc for legitimate investment reasons having nothing to do with that announcement.\"</li><li><a href=\"https://seekingalpha.com/news/3336619-manitowoc-big-loser-trump-s-steel-tariffs-j-p-morgan-says\" target=\"_blank\">Earlier</a>: Manitowoc could be big loser from Trump's steel tariffs, J.P. Morgan says (Mar. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337211\" data-linked=\"Icahn says suggestion of insider trading on Manitowoc &#39;categorically untrue&#39;\" data-tweet=\"$MTW - Icahn says suggestion of insider trading on Manitowoc &#39;categorically untrue&#39; https://seekingalpha.com/news/3337211-icahn-says-suggestion-of-insider-trading-on-manitowoc-categorically-untrue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337211-icahn-says-suggestion-of-insider-trading-on-manitowoc-categorically-untrue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337205\" data-ts=\"1520443029\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337205-oragenics-up-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oragenics up 45%</a></h4><ul><li>Thinly traded nano cap Oragenics (<a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+44.8%</font>) is up on a healthy 35x surge in volume. Shares were up&nbsp;<font color='green'>116%</font>&nbsp;before retracing. No particular news accounts for the action.</li><li>At the end of December, it had $6.2M in quick assets. Operations consumed $6.4M in 2017 so a capital raise will be needed at some point.</li><li>The company's lead candidate is Phase 2-stage AG013 for the treatment of oral mucositis.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3226061-oragenics-lead-product-candidate-fast-trackd-u-s-oral-mucositis-shares-19-percent\" target=\"_blank\">Oragenics' lead product candidate Fast Track'd in U.S. for oral mucositis; shares up 19%</a> (Nov. 21, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337205\" data-linked=\"Oragenics up 45%\" data-tweet=\"$OGEN - Oragenics up 45% https://seekingalpha.com/news/3337205-oragenics-up-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3337205-oragenics-up-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337204\" data-ts=\"1520442616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337204-gogominus-2_8-guggenheim-cuts-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo -2.8% as Guggenheim cuts to Neutral</a></h4><ul>   <li>Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>) is <font color='red'>2.8% lower</font> today after a downgrade to Neutral at Guggenheim.</li>    <li>The move makes for less consensus around Gogo expectations, with analysts nearly evenly split between Buy, Hold and Sell ratings.</li>    <li>Shares are <font color='red'>down 19.2%</font> YTD; the company just installed <a href=\"https://seekingalpha.com/news/3336569-gogo-ceo-steps\" target=\"_blank\">Oakleigh Thorne</a> as its new CEO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337204\" data-linked=\"Gogo -2.8% as Guggenheim cuts to Neutral\" data-tweet=\"$GOGO - Gogo -2.8% as Guggenheim cuts to Neutral https://seekingalpha.com/news/3337204-gogominus-2_8-guggenheim-cuts-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3337204-gogominus-2_8-guggenheim-cuts-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337203\" data-ts=\"1520442614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLE\" target=\"_blank\">XLE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337203-energy-sector-leads-markets-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy sector leads markets lower</a></h4><ul><li>Despite some <a href=\"https://seekingalpha.com/news/3337169-crude-futures-pares-losses-post-inventory-data\" target=\"_blank\">modestly bullish</a> inventory news, oil is&nbsp;<font color='red'>down 2.25%</font>&nbsp;today to $61.20.</li><li>Alongside, Exxon<a href=\"https://seekingalpha.com/news/3337134-exxon-seeks-double-earnings-cash-flow-2025\" target=\"_blank\"> this morning promised </a>an aggressive approach to spending/growth, but offered nothing in the way of buybacks. It's&nbsp;<font color='red'>down 3.1%</font>.</li><li>The Energy Select SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>) is<font color='red'> down 1.4%</font>, about doubling the S&amp;P 500's decline.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337203\" data-linked=\"Energy sector leads markets lower\" data-tweet=\"$XLE - Energy sector leads markets lower https://seekingalpha.com/news/3337203-energy-sector-leads-markets-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3337203-energy-sector-leads-markets-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337201\" data-ts=\"1520442063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RELV\" target=\"_blank\">RELV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337201-consumer-top-gainers-losers-of-12-00-pm-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (3/7/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/RELV' title='Reliv&#39; International, Inc.'>RELV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MERC' title='Mercer International Inc.'>MERC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337201\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (3/7/2018)\" data-tweet=\"$RELV $RELV $ZXAIY - Consumer - Top Gainers / Losers as of 12:00 pm (3/7/2018) https://seekingalpha.com/news/3337201-consumer-top-gainers-losers-of-12-00-pm-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337201-consumer-top-gainers-losers-of-12-00-pm-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337198\" data-ts=\"1520441335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTS\" target=\"_blank\">QTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337198-data-center-reits-on-rise-amid-strong-analyst-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Data-center REITs on rise amid strong analyst optimism</a></h4><ul>   <li>With a healthy conference schedule this week for data-center REITs, the group's on the move higher amid some robust analyst outlooks.</li>    <li>Higher today: <a href='https://seekingalpha.com/symbol/QTS' title='QTS Realty Trust, Inc.'>QTS</a> <font color='green'>+4.3%</font>; <a href='https://seekingalpha.com/symbol/DLR' title='Digital Realty Trust, Inc.'>DLR</a> <font color='green'>+1.5%</font>; <a href='https://seekingalpha.com/symbol/COR' title='CoreSite Realty Corporation'>COR</a> <font color='green'>+1%</font>; <a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a> <font color='green'>+3.5%</font>; <a href='https://seekingalpha.com/symbol/CONE' title='CyrusOne'>CONE</a> <font color='green'>+0.4%</font>. Equinix (NASDAQ:<a href='https://seekingalpha.com/symbol/EQIX' title='Equinix, Inc.'>EQIX</a>), by contrast, is near flat.</li>    <li>Wells Fargo's Jennifer Fritzsche favors <a href='https://seekingalpha.com/symbol/DLR' title='Digital Realty Trust, Inc.'>DLR</a>, <a href='https://seekingalpha.com/symbol/EQIX' title='Equinix, Inc.'>EQIX</a>, <a href='https://seekingalpha.com/symbol/CONE' title='CyrusOne'>CONE</a>, <a href='https://seekingalpha.com/symbol/QTS' title='QTS Realty Trust, Inc.'>QTS</a> and <a href='https://seekingalpha.com/symbol/COR' title='CoreSite Realty Corporation'>COR</a>, noting that investor worries in the sector are overblown. (h/t Bloomberg)</li>    <li>QTS last week saw its price target cut to $34 by Deutsche Bank, but DB's Vin Chao came away from the bank's Media, Telecom and Business Services Conference impressed by the sector overall, seeing a message of strong and accelerating demand that should lead to higher growth.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337198\" data-linked=\"Data-center REITs on rise amid strong analyst optimism\" data-tweet=\"$QTS $QTS $DLR - Data-center REITs on rise amid strong analyst optimism https://seekingalpha.com/news/3337198-data-center-reits-on-rise-amid-strong-analyst-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3337198-data-center-reits-on-rise-amid-strong-analyst-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337195\" data-ts=\"1520441086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUN\" target=\"_blank\">RUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337195-sunrun-claims-top-spot-in-u-s-home-solar-market-sharesminus-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunrun claims top spot in U.S. home solar market but shares -8%</a></h4><ul>     <li>Sunrun (<a href='https://seekingalpha.com/symbol/RUN' title='Sunrun'>RUN</a> <font color='red'>-8.5%</font>) says it is now the <a href=\"https://renewablesnow.com/news/sunrun-takes-the-lead-from-tesla-in-us-home-solar-market-604177/\" target=\"_blank\">biggest U.S. residential solar installer</a> with 85 MW of deployments in Q4, up 10% Y/Y although slightly short of company guidance of 87 MW.</li>     <li>Tesla's energy and storage division recently reported 87 MW of solar deployments, but the total included commercial and industrial systems as well as residential.</li>     <li>But shares are sharply lower after <a href=\"https://seekingalpha.com/news/3336880-sunrun-misses-0_13-beats-revenue\" target=\"_blank\">Q4 earnings</a> missed expectations even as revenues rose 21% Y/Y and unlevered NPV of $1.22/watt was the highest level in the company's history.</li>     <li>RUN says it deployed 323 MW for the full year, up 15% Y/Y, and it forecasts another 15% increase for 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337195\" data-linked=\"Sunrun claims top spot in U.S. home solar market but shares -8%\" data-tweet=\"$RUN - Sunrun claims top spot in U.S. home solar market but shares -8% https://seekingalpha.com/news/3337195-sunrun-claims-top-spot-in-u-s-home-solar-market-sharesminus-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3337195-sunrun-claims-top-spot-in-u-s-home-solar-market-sharesminus-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337194\" data-ts=\"1520441085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337194-ad-com-renders-split-vote-on-amgens-blincyto-in-type-of-all-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ad Com renders split vote on Amgen&#39;s Blincyto in type of ALL; shares down 1%</a></h4><ul><li>Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-1%</font>) slips on light volume as investors appear unconcerned about a split Ad Com vote on BLINCYTO (blinatumomab) for the treatment of minimal residual disease-positive B-cell precursor acute lymphoblastic leukemia &#40;ALL&#41;. The committee voted 8 - 4 that the benefits outweigh the risks.</li><li>The FDA's action date is March 29 under accelerated review status.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3336379-ad-com-wednesday-expanded-use-amgens-blincyto\" target=\"_blank\">Ad Com Wednesday for expanded use of Amgen's Blincyto</a> (March 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337194\" data-linked=\"Ad Com renders split vote on Amgen&#39;s Blincyto in type of ALL; shares down 1%\" data-tweet=\"$AMGN - Ad Com renders split vote on Amgen&#39;s Blincyto in type of ALL; shares down 1% https://seekingalpha.com/news/3337194-ad-com-renders-split-vote-on-amgens-blincyto-in-type-of-all-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3337194-ad-com-renders-split-vote-on-amgens-blincyto-in-type-of-all-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337193\" data-ts=\"1520441031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337193-dollar-tree-drop-seen-overdone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar Tree drop seen as overdone</a></h4><ul> <li>Several firms have pushed out notes indicating that the sell-off in Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='red'>-14.9%</font>) may be overdone.</li> <li>Wells Fargo and Guggenheim have similar messages on the conservative guidance issued by the retailer that could set it up for earnings beats down the road.</li> <li>Also, the $100M investment by Dollar Tree in store hours, hourly wages and employee benefits is expected to pay off down the road.</li> <li>Shares of Dollar Tree trade at their lowest level since late October.</li><li>Sources: Bloomberg, MarketWatch</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337069-dollar-tree-misses-0_01-misses-revenue\" target=\"_blank\">Dollar Tree misses by $0.01, misses on revenue</a> (March 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337095-dollar-tree-falls-earnings-miss\" target=\"_blank\">Dollar Tree falls on earnings miss</a> (March 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337193\" data-linked=\"Dollar Tree drop seen as overdone\" data-tweet=\"$DLTR - Dollar Tree drop seen as overdone https://seekingalpha.com/news/3337193-dollar-tree-drop-seen-overdone?source=tweet\" data-url=\"https://seekingalpha.com/news/3337193-dollar-tree-drop-seen-overdone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337189\" data-ts=\"1520440119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBE\" target=\"_blank\">OBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337189-obsidian-energyminus-5-after-proposing-3-forminus-1-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obsidian Energy -5% after proposing 3-for-1 reverse split</a></h4><ul>     <li>Obsidian Energy (<a href='https://seekingalpha.com/symbol/OBE' title='Obsidian Energy Ltd.'>OBE</a> <font color='red'>-5.1%</font>)&nbsp;plunges after proposing a three-for-one consolidation of its common shares, along with <a href=\"https://seekingalpha.com/news/3337035-obsidian-energy-misses-0_08\" target=\"_blank\">Q4 earnings</a> results.</li>     <li>OBE says FY 2017 production was 31.7K boe/day, above the high end of its 30.5K-31.5 boe/day guidance range, while Q4 output was 31.4K boe/day, up 10% Y/Y and up 4% Q/Q.</li>     <li>Q4 operating costs were $12.50/boe, consistent with Q3 and ~$2/boe below H1 2017, which had higher maintenance and turnaround activity.</li><li>OBE's FY 2018 guidance remains unchanged: production of 29K-30K boe/day, up ~5% Y/Y; operating costs of $13.00-$13.50/boe; total capex of $135M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337189\" data-linked=\"Obsidian Energy -5% after proposing 3-for-1 reverse split\" data-tweet=\"$OBE - Obsidian Energy -5% after proposing 3-for-1 reverse split https://seekingalpha.com/news/3337189-obsidian-energyminus-5-after-proposing-3-forminus-1-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3337189-obsidian-energyminus-5-after-proposing-3-forminus-1-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337188\" data-ts=\"1520439916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337188-pacific-bio-announces-enhancements-to-sequel-system-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Bio announces enhancements to Sequel System; shares up 10%</a></h4><ul><li>Pacific Biosciences (<a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='green'>+9.5%</font>) is up on modestly higher volume in response to its <a href=\"http://investor.pacificbiosciences.com/news-releases/news-release-details/pacific-biosciences-enhances-performance-and-affordability-key\" target=\"_blank\">announcement </a>of new software and polymerase for its <a href=\"https://www.pacb.com/products-and-services/pacbio-systems/sequel/\" target=\"_blank\">Sequel System</a> that will double its throughput.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337188\" data-linked=\"Pacific Bio announces enhancements to Sequel System; shares up 10%\" data-tweet=\"$PACB - Pacific Bio announces enhancements to Sequel System; shares up 10% https://seekingalpha.com/news/3337188-pacific-bio-announces-enhancements-to-sequel-system-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3337188-pacific-bio-announces-enhancements-to-sequel-system-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337187\" data-ts=\"1520439690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADSK\" target=\"_blank\">ADSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337187-autodeskplus-12_2-amid-analyst-positivity-on-recurring-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autodesk +12.2% amid analyst positivity on recurring revenue</a></h4><ul>   <li>Autodesk (NASDAQ:<a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a>) is <font color='green'>up 12.2%</font> after earnings that showed a <a href=\"https://seekingalpha.com/news/3336933-autodesk-plus-10-percent-q4-beats-downside-guidance\" target=\"_blank\">narrower loss than expected</a> and impressed analysts watching a move toward subscription-based business more than a decline in net adds.</li>    <li>RBC <a href=\"https://www.streetinsider.com/Analyst+Comments/Autodesk+%28ADSK%29+PT+Raised+to+%24156+at+RBC+Capital%3B+Strong+ARR/13912654.html\" target=\"_blank\">boosted its price target to $156</a> from $140, pointing to positives in Q4 ARR (and higher guidance for fiscal 2019) and reiterated targets for ARR/FCF in fiscal 2020.</li>    <li>Cowen was among many analysts who said soft subscriber growth was less important than recurring revenue guidance and noted stronger customer conversions to its Collections suite had the effect of boosting ARR while putting downward pressure on net adds.  The firm raised its target to $140 from $130. (h/t Bloomberg)</li>    <li>Canaccord Genuity raised its price target to $150 from $135; Wedbush boosted to $130 from $126.</li>    <li>KeyBanc (which raised its price target to $138 from $134) attributes a higher forecast in average revenue per subscriber in part to a mix shift to higher value products, along with less discounting/promotion.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337187\" data-linked=\"Autodesk +12.2% amid analyst positivity on recurring revenue\" data-tweet=\"$ADSK - Autodesk +12.2% amid analyst positivity on recurring revenue https://seekingalpha.com/news/3337187-autodeskplus-12_2-amid-analyst-positivity-on-recurring-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337187-autodeskplus-12_2-amid-analyst-positivity-on-recurring-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337160\" data-ts=\"1520438545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OGEN\" target=\"_blank\">OGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337160-healthcare-top-5-gainers-losers-of-11-00-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/7/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OGEN' title='Oragenics, Inc.'>OGEN</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CLSD' title='Clearside Biomedical'>CLSD</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MYOK' title='MyoKardia'>MYOK</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337160\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/7/2018)\" data-tweet=\"$OGEN $OGEN $RGNX - Healthcare - Top 5 Gainers / Losers as of 11:00 am (3/7/2018) https://seekingalpha.com/news/3337160-healthcare-top-5-gainers-losers-of-11-00-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337160-healthcare-top-5-gainers-losers-of-11-00-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337180\" data-ts=\"1520438080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNSDF\" target=\"_blank\">RNSDF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337180-renault-spikes-on-report-of-nissan-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renault spikes on report of Nissan stake</a></h4><ul> <li>Shares of Renault (<a href='https://seekingalpha.com/symbol/RNSDF' title='Renault SA'>OTC:RNSDF</a>, <a href='https://seekingalpha.com/symbol/RNLSY' title='Renault SA ADR'>OTCPK:RNLSY</a>) are&nbsp;<font color='green'>up 11%</font>&nbsp;in Paris after Reuters <a href=\"https://www.reuters.com/article/us-renault-nissan-m-a-exclusive/exclusive-nissan-in-talks-to-buy-frances-renault-stake-in-merger-prelude-idUSKCN1GJ2A7?il=0\" target=\"_blank\">reports</a> that Nissan may take a larger stake.</li><li>Sources indicate that Nissan may buy the shares directly from the French government.</li><li>The sale could have some political hurdles to clear before being finalized.</li><li>Plans for a full merger between Renault and Nissan have been nipped in the bud by the French government in the past.</li>  <li>Previously: <a href=\"https://seekingalpha.com/news/3337133-renault-alibaba-advance-partnership\" target=\"_blank\">Renault and Alibaba advance partnership</a> (March 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337180\" data-linked=\"Renault spikes on report of Nissan stake\" data-tweet=\"$RNSDF $RNSDF $RNLSY - Renault spikes on report of Nissan stake https://seekingalpha.com/news/3337180-renault-spikes-on-report-of-nissan-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3337180-renault-spikes-on-report-of-nissan-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337176\" data-ts=\"1520437424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337176-takeover-chatter-sends-amd-flying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Takeover chatter sends AMD flying</a></h4><ul> <li>There's a big pop with Advanced Micro Devices (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+6.4%</font>) after takeover rumors circulate around trading desks.</li> <li>Bloomberg reports options trading on AMD is elevated as March calls in particular get snapped up.</li> <li>AMD has traded as high as $12.54 today.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337176\" data-linked=\"Takeover chatter sends AMD flying\" data-tweet=\"$AMD - Takeover chatter sends AMD flying https://seekingalpha.com/news/3337176-takeover-chatter-sends-amd-flying?source=tweet\" data-url=\"https://seekingalpha.com/news/3337176-takeover-chatter-sends-amd-flying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>313&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337175\" data-ts=\"1520437228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337175-cohn-tantrum-cools\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cohn tantrum cools</a></h4><ul><li>At their worst levels, stock index futures were&nbsp;<font color='red'>down well over 1%</font>&nbsp;in wake of the departure of chief economic advisor Gary Cohn from the White House, but the dip-buyers have moved in since the opening bell.</li><li>The S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) is&nbsp;<font color='red'>down 0.3%</font>, the Dow (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>)&nbsp;<font color='red'>0.4</font><font color='red'>%</font>, and the Nasdaq (NASDAQ:<a href='https://seekingalpha.com/symbol/QQQ' title='PowerShares QQQ Trust ETF'>QQQ</a>) is flat.</li><li>The 10-year Treasury yield is down two basis points to 2.87%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337064-navarro-ascendant-white-house-letting-trump-trump\" target=\"_blank\">Navarro ascendant at White House - letting \"Trump be Trump\"</a> (March 7)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337175\" data-linked=\"Cohn tantrum cools\" data-tweet=\"$SPY $DIA $QQQ - Cohn tantrum cools https://seekingalpha.com/news/3337175-cohn-tantrum-cools?source=tweet\" data-url=\"https://seekingalpha.com/news/3337175-cohn-tantrum-cools\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>62&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337174\" data-ts=\"1520437070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BGS\" target=\"_blank\">BGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337174-credit-suisse-warns-on-b-and-g-foods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse warns on B&amp;G Foods</a></h4><ul> <li>B&amp;G Foods (<a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a> <font color='red'>-7.4%</font>) falls after Credit Suisse jumps in with a downgrade on the food stock to Underperform from Neutral on its expectation for more downward guidance revisions from management.</li> <li>\"The EBITDA guidance for 2018 relies too heavily, in our view, the core business&rsquo;s ability to increase pricing to offset freight inflation and the distribution losses in Green Giant&rsquo;s canned vegetables. As has been the case historically, we expect a highly elastic response to volume when these brands raise prices,\" writes CS analyst Robert Moskow.</li> <li>B&amp;G's acquisitions of complex businesses is seen as adding a layer of risk to the stock as the company bumps up against larger competitors with an advantage.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337174\" data-linked=\"Credit Suisse warns on B&amp;G Foods\" data-tweet=\"$BGS - Credit Suisse warns on B&amp;G Foods https://seekingalpha.com/news/3337174-credit-suisse-warns-on-b-and-g-foods?source=tweet\" data-url=\"https://seekingalpha.com/news/3337174-credit-suisse-warns-on-b-and-g-foods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337162\" data-ts=\"1520435480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INXN\" target=\"_blank\">INXN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337162-interxionplus-6_2-on-solid-q4-revenue-growth-upbeat-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterXion +6.2% on solid Q4 revenue growth, upbeat guidance</a></h4><ul>   <li>InterXion (NYSE:<a href='https://seekingalpha.com/symbol/INXN' title='InterXion Holding N.V.'>INXN</a>) has <font color='green'>gained 6.2%</font> after its <a href=\"https://seekingalpha.com/news/3337050-interxion-holding-reports-q4-results\" target=\"_blank\">Q4 results</a> where revenues grew double digits and the company guided higher for 2018.</li>    <li>Revenues rose 18%; recurring revenue was up 19% Y/Y (and rose 5% sequentially) to &euro;123.4M.</li>    <li>On an organic constant currency basis, revenue rose 17% (and 4% sequentially).</li>    <li>Operating income was up 20% to &euro;27M; net income rose 9% to &euro;11M.</li>    <li>EBITDA also rose 20%, to &euro;59.1M.</li>    <li>Equipped space rose by 3,600 square meters to 122,500; revenue-generating space rose by 2,700 square meters to 99,800. Utilization rate at year's end was 81%.</li>    <li>For 2018, it's guiding to revenues of &euro;553M-&euro;569M (above consensus for &euro;543.5M), EBITDA of &euro;250M-&euro;260M (vs. expectations for &euro;250.3M), and capex of &euro;335M-&euro;365M.</li>    <li><a href=\"https://seekingalpha.com/pr/17094604-interxion-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337162\" data-linked=\"InterXion +6.2% on solid Q4 revenue growth, upbeat guidance\" data-tweet=\"$INXN - InterXion +6.2% on solid Q4 revenue growth, upbeat guidance https://seekingalpha.com/news/3337162-interxionplus-6_2-on-solid-q4-revenue-growth-upbeat-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3337162-interxionplus-6_2-on-solid-q4-revenue-growth-upbeat-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337158\" data-ts=\"1520434917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337158-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen nabs U.S. patent covering lead candidate AV-101; shares up 3%</a></h4><ul><li>The USPTO <a href=\"https://seekingalpha.com/pr/17095133-vistagen-therapeutics-receives-notice-allowance-key-u-s-patent-covering-treatment-depression\" target=\"_blank\">issues </a>a Notice of Allowance to VistaGen Therapeutics (<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='green'>+3.4%</font>) for its patent application No. 15/018,219 related to methods of treating depression with AV-101, currently in Phase 2 development for major depressive disorder &#40;MDD&#41;. When issued, the patent will be in effect until at least 2034.</li><li><a href=\"http://www.vistagen.com/?page_id=11\" target=\"_blank\">AV-101</a>&nbsp;is an orally available central nervous system &#40;CNS&#41; prodrug that is converted in the brain by cells called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Astrocyte\" target=\"_blank\">astrocytes&nbsp;</a>into its active metabolite, 7-chlorokynurenic acid (7-CI-KYNA), a highly selective antagonist of certain receptors &#40;NMDA&#41;&nbsp;that play key roles in neurodegenerative diseases like epilepsy, MDD and neuropathic pain.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320888-vistagens-avminus-101-fast-trackd-u-s-major-depressive-disorder-shares-11-percent-premarket\" target=\"_blank\">VistaGen's AV-101 Fast Track'd in U.S. for major depressive disorder; shares up 11% premarket</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337158\" data-linked=\"VistaGen nabs U.S. patent covering lead candidate AV-101; shares up 3%\" data-tweet=\"$VTGN - VistaGen nabs U.S. patent covering lead candidate AV-101; shares up 3% https://seekingalpha.com/news/3337158-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3337158-vistagen-nabs-u-s-patent-covering-lead-candidate-avminus-101-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337153\" data-ts=\"1520434513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337153-aytu-bios-mioxsys-okd-in-mexico-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aytu Bio&#39;s MiOXSYS OK&#39;d in Mexico; shares up 2%</a></h4><ul><li>Mexican regulators have <a href=\"https://seekingalpha.com/pr/17094858-aytu-bioscience-receives-market-registration-mioxsys-system-male-infertility-mexico\" target=\"_blank\">approved </a>Aytu BioSciences' (<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a> <font color='green'>+2.4%</font>) MiOXSYS System for male infertility. The product will be exclusively distributed by IMP Medica.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337153\" data-linked=\"Aytu Bio&#39;s MiOXSYS OK&#39;d in Mexico; shares up 2%\" data-tweet=\"$AYTU - Aytu Bio&#39;s MiOXSYS OK&#39;d in Mexico; shares up 2% https://seekingalpha.com/news/3337153-aytu-bios-mioxsys-okd-in-mexico-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3337153-aytu-bios-mioxsys-okd-in-mexico-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337152\" data-ts=\"1520434185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTX\" target=\"_blank\">BTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337152-biotime-advances-clinical-trial-of-opregen-in-dry-amd-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioTime advances clinical trial of OpRegen in dry AMD; shares up 2%</a></h4><ul><li>BioTime (<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a> <font color='green'>+1.5%</font>) <a href=\"https://seekingalpha.com/pr/17094747-biotime-announces-dsmb-approval-proceed-cohort-4-opregen-clinical-trial\" target=\"_blank\">announces </a>that the independent Data Safety Monitoring Board has signed off on the initiation of the fourth cohort in its Phase 1/2b clinical trial assessing stem cell therapy OpRegen in patients with dry-AMD. The new group will include patients with earlier stages of the disease who have better vision. Preliminary data should be available in Q4.</li><li><a href=\"http://www.biotimeinc.com/products-pipeline/opregen/\" target=\"_blank\">OpRegen </a>is a suspension of retinal pigment epithelial cells that is delivered under the retina via intraocular injection.</li><li>Previously: <a href=\"https://seekingalpha.com/news/2085045-fda-clears-biotimes-ind-for-amd-stem-cell-therapeutic-candidate\" target=\"_blank\">FDA clears BioTime's IND for AMD stem cell therapeutic candidate</a> (Nov. 3, 2014)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337152\" data-linked=\"BioTime advances clinical trial of OpRegen in dry AMD; shares up 2%\" data-tweet=\"$BTX $LCTX - BioTime advances clinical trial of OpRegen in dry AMD; shares up 2% https://seekingalpha.com/news/3337152-biotime-advances-clinical-trial-of-opregen-in-dry-amd-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3337152-biotime-advances-clinical-trial-of-opregen-in-dry-amd-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337151\" data-ts=\"1520434098\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337151-momoplus-6_9-after-q4-user-growth-reaccelerates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo +6.9% after Q4 user growth reaccelerates</a></h4><ul>   <li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a>) is hot out of the gate, <font color='green'>up 6.9%</font>, after <a href=\"https://seekingalpha.com/news/3337008-momo-beats-0_07-beats-revenue\" target=\"_blank\">Q4 earnings</a> where it sharply increased live-video revenues and sped up user growth.</li>    <li>Net income attributable to Momo (non-GAAP) rose 20%, to $110M.</li>    <li>Monthly active users came to 99.1M in December, vs. a prior-year 81.1M. Paying users came to 4.3M and spurred video revenue growth.</li>    <li>Revenue breakout: Live video service, $328M (up 68.3%); Value-added service, $29.4M (up 54.1%); Mobile marketing, $21.8M (up 10.6%); Mobile games, $6.9M (down 39%); other, $260,000 vs. year-ago $1.18M.</li>    <li>Cash from operations was $119.6M vs. a prior-year $107.2M. As of Dec. 31, cash, equivalents and term deposits came to $1.06B vs. a prior-year $651.3M.</li>    <li>For Q1, it's guiding to net revenues of $387M-$402M (up 46-52% Y/Y), well above consensus for $370.5M.</li>    <li><a href=\"https://seekingalpha.com/pr/17094499-momo-announces-unaudited-financial-results-fourth-quarter-fiscal-year-2017\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3337151\" data-linked=\"Momo +6.9% after Q4 user growth reaccelerates\" data-tweet=\"$MOMO - Momo +6.9% after Q4 user growth reaccelerates https://seekingalpha.com/news/3337151-momoplus-6_9-after-q4-user-growth-reaccelerates?source=tweet\" data-url=\"https://seekingalpha.com/news/3337151-momoplus-6_9-after-q4-user-growth-reaccelerates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337143\" data-ts=\"1520432857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337143-sellas-life-sciences-down-14-premarket-on-10_7m-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SELLAS Life Sciences down 14% premarket on $10.7M capital raise</a></h4><ul><li>SELLAS Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a>) slips&nbsp;<font color='red'>14%</font>&nbsp;premarket on light volume in response to its private $10.7M <a href=\"https://seekingalpha.com/pr/17095124-sellas-life-sciences-announces-10700-000-private-placement\" target=\"_blank\">capital raise</a> via the sale of convertible preferred stock and warrants to certain institutional investors.</li><li>Net proceeds will fund pipeline development and general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337143\" data-linked=\"SELLAS Life Sciences down 14% premarket on $10.7M capital raise\" data-tweet=\"$SLS - SELLAS Life Sciences down 14% premarket on $10.7M capital raise https://seekingalpha.com/news/3337143-sellas-life-sciences-down-14-premarket-on-10_7m-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3337143-sellas-life-sciences-down-14-premarket-on-10_7m-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337130\" data-ts=\"1520431840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARE\" target=\"_blank\">RARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337130-ultragenyx-reports-encouraging-data-from-phase-1-2-study-of-gene-therapy-dtx301-in-otc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultragenyx reports encouraging data from Phase 1/2 study of gene therapy DTX301 in OTC deficiency</a></h4><ul><li>Ultragenyx Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>) is unchanged premarket in response to its <a href=\"https://seekingalpha.com/pr/17094823-ultragenyx-announces-positive-topline-results-dmc-review-first-cohort-phase-1-2-clinical\" target=\"_blank\">announcement </a>of positive preliminary data from a Phase 1/2 clinical trial evaluating gene therapy DTX301 in patients with <a href=\"https://ghr.nlm.nih.gov/condition/ornithine-transcarbamylase-deficiency\" target=\"_blank\">ornithine transcarbamylase &#40;OTC&#41; deficiency</a>, an inherited disorder characterized by the accumulation of ammonia in the body. OTC, an enzyme, plays a key role in the urea cycle (breakdown and removal of nitrogen).</li><li>The company says patient #1 in the lowest-dose cohort has experienced increased levels of ureagenesis (formation of urea) through 24 weeks, has discontinued other medications and continues to do well.</li><li>The other two patients in the cohort, followed for 20 weeks and 12 weeks, respectively, have not shown clinically meaningful changes in urea formulation rate.</li><li>On the safety front, no infusion-related adverse events and no serious adverse events have been reported. Two patients experienced mild elevations in an enzyme called alanine aminotransferase &#40;ALT&#41;, a biomarker for liver damage, that were effectively managed with corticosteroids.</li><li>The Data Monitoring Committee has signed off on the advancement to a second higher-dose cohort. Top-line data should be available in H2.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3312888-ultragenyx-completes-dosing-first-cohort-phase-1-2-study-dtx301-otc-deficiency\" target=\"_blank\">Ultragenyx completes dosing in first cohort of Phase 1/2 study of DTX301 in OTC deficiency</a> (Nov. 16, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3337130\" data-linked=\"Ultragenyx reports encouraging data from Phase 1/2 study of gene therapy DTX301 in OTC deficiency\" data-tweet=\"$RARE - Ultragenyx reports encouraging data from Phase 1/2 study of gene therapy DTX301 in OTC deficiency https://seekingalpha.com/news/3337130-ultragenyx-reports-encouraging-data-from-phase-1-2-study-of-gene-therapy-dtx301-in-otc?source=tweet\" data-url=\"https://seekingalpha.com/news/3337130-ultragenyx-reports-encouraging-data-from-phase-1-2-study-of-gene-therapy-dtx301-in-otc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337129\" data-ts=\"1520431818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337129-premarket-gainers-of-9-05-03-07-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (03/07/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/MOMO' title='Momo'>MOMO</a> <font color='green'>+13%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3337008-momo-beats-0_07-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/ADSK' title='Autodesk, Inc.'>ADSK</a> <font color='green'>+11%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3336879-autodesk-beats-0_02-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a> <font color='green'>+10%&nbsp;</font>on Bio out-<a href=\"https://seekingalpha.com/news/3337065-aptose-bio-licenses-aplminus-581-125m-shares-13-percent-premarket\" target=\"_blank\">licenses</a> APL-581 for up to $125M.</li><li><a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a> <font color='green'>+7%</font>&nbsp;will <a href=\"https://seekingalpha.com/news/3337104-formfactor-tapped-s-and-p-smallcap-600-shares-plus-6-percent-premarket\" target=\"_blank\">join</a> S&amp;P Smallcap 600.</li><li><a href='https://seekingalpha.com/symbol/MNGA' title='MagneGas Corporation'>MNGA</a> <font color='green'>+5%</font>&nbsp;as green arc sales force to <a href=\"https://seekingalpha.com/pr/17094684-magnegas-expand-green-arc-sales-force-60-percent-first-quarter-2018\" target=\"_blank\">expand</a> by 60% in 1Q18.</li><li><a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+7%</font>&nbsp;on Q4&nbsp;<a href=\"https://seekingalpha.com/news/3337067-abercrombie-and-fitch-beats-0_28-beats-revenue\" target=\"_blank\">result</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337129\" data-linked=\"Premarket Gainers as of 9:05 am (03/07/2018)\" data-tweet=\"$MOMO $MOMO $ADSK - Premarket Gainers as of 9:05 am (03/07/2018) https://seekingalpha.com/news/3337129-premarket-gainers-of-9-05-03-07-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337129-premarket-gainers-of-9-05-03-07-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337128\" data-ts=\"1520431758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVNA\" target=\"_blank\">CVNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337128-premarket-losers-of-9-05-3-7-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (3/7/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CVNA' title='Carvana Co.'>CVNA</a>&nbsp;<font color='red'>-14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336928-carvana-misses-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a>&nbsp;<font color='red'>-12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3337069-dollar-tree-misses-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336895-transenterix-misses-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336949-t2-biosystems-eps-0_35\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3336642-baozun-beats-0_11-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337128\" data-linked=\"Premarket Losers as of 9:05 am (3/7/2018)\" data-tweet=\"$CVNA $CVNA $DLTR - Premarket Losers as of 9:05 am (3/7/2018) https://seekingalpha.com/news/3337128-premarket-losers-of-9-05-3-7-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3337128-premarket-losers-of-9-05-3-7-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337127\" data-ts=\"1520431650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIXY\" target=\"_blank\">PIXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337127-shiftpixy-rallies-after-blockchain-statement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ShiftPixy rallies after blockchain statement</a></h4><ul> <li>ShiftPixy (NASDAQ:<a href='https://seekingalpha.com/symbol/PIXY' title='ShiftPixy'>PIXY</a>) races higher in early trading after the company issues a <a href=\"https://seekingalpha.com/pr/17094789-shiftpixys-blockchain-use-case\" target=\"_blank\">release</a> on the blockchain use case that the company plans to utilize with human capital transactions.</li> <li>ShiftyPixy CEO Scott Absher: \"We use blockchain technology in our ecosystem, because it is one of the most efficient tools available to help us protect our data from cyber interference. Any data considered to be a human capital validation point or part of the hiring and onboarding process is being utilized and recorded in ShiftPixy's blockchain ledger.\"</li> <li>Shares of ShiftPixy are&nbsp;<font color='green'>up 10.90%</font>&nbsp;in premarket trading.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337127\" data-linked=\"ShiftPixy rallies after blockchain statement\" data-tweet=\"$PIXY - ShiftPixy rallies after blockchain statement https://seekingalpha.com/news/3337127-shiftpixy-rallies-after-blockchain-statement?source=tweet\" data-url=\"https://seekingalpha.com/news/3337127-shiftpixy-rallies-after-blockchain-statement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337121\" data-ts=\"1520431002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337121-positive-outlook-from-caseys-general-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive outlook from Casey&#39;s General Stores</a></h4><ul> <li>Casey's General Stores (NASDAQ:<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a>) squeezes past the consensus estimate on <a href=\"https://seekingalpha.com/pr/17095000-caseys-discloses-increased-value-creation-plan-reports-third-quarter-results\" target=\"_blank\">FQ3</a> revenue as same-store grocery sales rose 2.5%.</li> <li>Same-store fuel gallons sold were up 3.8% during the quarter, while same-store prepared food sales rose 1.7%.</li> <li>Casey's on capital allocation: \"Casey's plans to allocate additional capital in FY 2019 and beyond toward opportunities to increase shareholder value. In FY 2019, Casey's anticipates at least $150 million of incremental capital available relative to FY 2018 due to reduced remodel and replacement requirements combined with anticipated tax reform benefits.\"</li> <li>Looking ahead, Casey's expects FY21 same-store sales growth of 4% for fuel gallons, 6% for grocery and 10% for prepared food.</li><li>CASY&nbsp;<font color='red'>-0.27%</font>&nbsp;premarket to $110.86.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3337116-caseys-general-stores-misses-0_15-beats-revenue\" target=\"_blank\">Caseys General Stores misses by $0.15, beats on revenue</a> (March 7)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337121\" data-linked=\"Positive outlook from Casey&#39;s General Stores\" data-tweet=\"$CASY - Positive outlook from Casey&#39;s General Stores https://seekingalpha.com/news/3337121-positive-outlook-from-caseys-general-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3337121-positive-outlook-from-caseys-general-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337112\" data-ts=\"1520429824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDLZ\" target=\"_blank\">MDLZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337112-mondelez-drops-huge-block-being-shopped\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mondelez drops with huge block being shopped</a></h4><ul> <li>A block of 19.5M shares of Mondelez International (NASDAQ:<a href='https://seekingalpha.com/symbol/MDLZ' title='Mondelz International, Inc.'>MDLZ</a>) being sold by an unknown party is being priced at $43.90 per share, according to Bloomberg.</li> <li>Average daily volume on Mondelez is 9.41M shares.</li> <li>Shares of Mondelez are&nbsp;<font color='red'>down 4.21%</font>&nbsp;premarket to $43.65.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3337112\" data-linked=\"Mondelez drops with huge block being shopped\" data-tweet=\"$MDLZ - Mondelez drops with huge block being shopped https://seekingalpha.com/news/3337112-mondelez-drops-huge-block-being-shopped?source=tweet\" data-url=\"https://seekingalpha.com/news/3337112-mondelez-drops-huge-block-being-shopped\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337104\" data-ts=\"1520429274\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FORM\" target=\"_blank\">FORM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337104-formfactor-tapped-for-s-and-p-smallcap-600-sharesplus-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FormFactor tapped for S&amp;P Smallcap 600; shares +6% premarket</a></h4><ul>     <li>FormFactor (NASDAQ:<a href='https://seekingalpha.com/symbol/FORM' title='FormFactor, Inc.'>FORM</a>) <font color='green'>+6.2%</font> premarket on news it will <a href=\"https://seekingalpha.com/pr/17094392-formfactor-set-join-s-and-p-smallcap-600\" target=\"_blank\">join the S&amp;P SmallCap 600</a>, replacing Calgon Carbon (NYSE:<a href='https://seekingalpha.com/symbol/CCC-OLD' title='Calgon Carbon Corporation'>CCC-OLD</a>), effective prior to the open of trading on March 12.</li>     <li>Kuraray Co. is acquiring Calgon Carbon in a transaction expected to be completed on or about March 9.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337104\" data-linked=\"FormFactor tapped for S&amp;P Smallcap 600; shares +6% premarket\" data-tweet=\"$FORM $FORM $CCC-OLD - FormFactor tapped for S&amp;P Smallcap 600; shares +6% premarket https://seekingalpha.com/news/3337104-formfactor-tapped-for-s-and-p-smallcap-600-sharesplus-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3337104-formfactor-tapped-for-s-and-p-smallcap-600-sharesplus-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337095\" data-ts=\"1520428521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DLTR\" target=\"_blank\">DLTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337095-dollar-tree-falls-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dollar Tree falls on earnings miss</a></h4><ul>     <li>Dollar Tree (NASDAQ:<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a>) reports Enterprise same-store sales rose 2.4% in <a href=\"https://seekingalpha.com/pr/17094679-dollar-tree-inc-reports-record-fourth-quarter-fiscal-2017-results\" target=\"_blank\">Q4</a>, driven by increases in average ticket and comparable transaction count.</li>     <li>Same-store sales for the Dollar Tree banner increased 3.8% (on a constant currency basis) and Family Dollar banner grew 1.0%</li>     <li>Gross profit rate improved 90 bps to 33%.</li>     <li>SG&amp;A expense rate leveraged 40 bps to 21.3% due to lower depreciation costs and lower repair and maintenance costs.</li>     <li>Operating margin rate expanded 130 bps to 11.7%.</li>     <li>Store count +501 Y/Y to 14,835.</li>     <li>Retail selling square footage +3.7% to 116.6M.</li>     <li><b>Q1 Guidance</b>: Net sales: $5.53B to $5.63B; Enterprise same-store sales:&nbsp;low single-digit increase; Diluted EPS: $1.18 to $1.25.</li>     <li><b>FY2018 Guidance</b>:&nbsp;Net sales: $22.7B to $23.12B; Same-store sales:&nbsp;low single-digit&nbsp;growth; Diluted EPS: $5.25 to $5.60; Selling square footage: +3.7% Y/Y.</li>     <li>DLTR&nbsp;<font color='red'>-9.93%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3337095\" data-linked=\"Dollar Tree falls on earnings miss\" data-tweet=\"$DLTR - Dollar Tree falls on earnings miss https://seekingalpha.com/news/3337095-dollar-tree-falls-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3337095-dollar-tree-falls-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337087\" data-ts=\"1520427760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESPR\" target=\"_blank\">ESPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337087-esperions-high-cholesterol-med-bempedoic-acid-successful-in-late-stage-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Esperion&#39;s high cholesterol med bempedoic acid successful in late-stage study</a></h4><ul><li>A Phase 3 clinical trial, Study 4, assessing Esperion's (NASDAQ:<a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a>) bempedoic acid in statin-intolerant patients atherosclerotic cardiovascular disease &#40;ASCVD&#41; or at high risk of ASCVD with elevated low-density lipoprotein cholesterol (LDL-C) <a href=\"https://seekingalpha.com/pr/17094690-esperion-announces-positive-top-line-results-first-pivotal-phase-3-study-bempedoic-acid\" target=\"_blank\">achieved the primary endpoint</a>.</li><li>Patients receiving a daily 180 mg dose of bempedoic acid for 12 weeks experienced a statistically significant 28% lowering of LDL-C compared to placebo (p&lt;0.001) and 23% lower from baseline. Patients in the treatment group also experienced a 33% reduction in a cardiovascular disease inflammation-related biomarker called C-reactive protein compared to a 2% increase in the control group (p&lt;0.001).</li><li>On the safety front, bempedoic acid was well-tolerated with no difference in the occurrence of adverse events compared to placebo.</li><li>Top-line data from two Phase 3 studies (Study 1 and Study 2) in patients with ASCVD on maximum doses of statins should be available in May and September, respectively.</li><li>Top-line data from another study in statin-intolerant ASCVD patients, Study 3, should be available in May.</li><li>Top-line data from another pivotal study (053 Study) assessing bempedoic acid combined with ezetimibe (Merck's Zetia) in ASCVD patients on maximum statins should be available in August.</li><li><a href=\"http://www.esperion.com/therapies-progress/etc-1002/\" target=\"_blank\">Bempedoic acid</a>&nbsp;is a small molecule that lowers cholesterol without the side effects associated with statins. Once in the liver, it converts into a derivative coenzyme which directly inhibits an enzyme called&nbsp;<a href=\"https://en.wikipedia.org/wiki/ATP_citrate_lyase\" target=\"_blank\">ATP citrate lyase</a>&nbsp;&#40;ACL&#41; which plays a key role in cholesterol and fatty acid synthesis.</li><li>Management will host a conference call this morning at 8:30 am ET to discuss the results.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337087\" data-linked=\"Esperion&#39;s high cholesterol med bempedoic acid successful in late-stage study\" data-tweet=\"$ESPR - Esperion&#39;s high cholesterol med bempedoic acid successful in late-stage study https://seekingalpha.com/news/3337087-esperions-high-cholesterol-med-bempedoic-acid-successful-in-late-stage-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3337087-esperions-high-cholesterol-med-bempedoic-acid-successful-in-late-stage-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337084\" data-ts=\"1520427467\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVN\" target=\"_blank\">TRVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337084-trevena-net-loss-improves-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trevena net loss improves in Q4</a></h4><ul><li>Trevena (<a href='https://seekingalpha.com/symbol/TRVN' title='Trevena, Inc.'>TRVN</a>) <a href=\"https://seekingalpha.com/pr/17094625-trevena-reports-full-year-2017-earnings\" target=\"_blank\">Q4 results</a>: Revenues: $0; R&amp;D Expense: $7.2M (-77.1%); SG&amp;A: $5.1M (+15.9%); Operating Loss: ($14.1M) (+60.6%); Net Loss: ($14.7M) (+59.3%); Loss Per Share: ($0.24) (+64.2%); Quick Assets: $66.1M (-40.2%).</li><li>No guidance given.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337084\" data-linked=\"Trevena net loss improves in Q4\" data-tweet=\"$TRVN - Trevena net loss improves in Q4 https://seekingalpha.com/news/3337084-trevena-net-loss-improves-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3337084-trevena-net-loss-improves-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337065\" data-ts=\"1520426021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTO\" target=\"_blank\">APTO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337065-aptose-bio-out-licenses-aplminus-581-for-up-to-125m-shares-up-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aptose Bio out-licenses APL-581 for up to $125M; shares up 13% premarket</a></h4><ul><li>Nano cap Aptose Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/APTO' title='Aptose Biosciences Inc.'>APTO</a>) is up&nbsp;<font color='green'>1</font>3%&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17094606-aptose-biosciences-announces-exclusive-license-agreement-dual-bet-kinase-targeting-program\" target=\"_blank\">announcement </a>that it has inked an exclusive global license agreement with OHM Oncology granting it development, manufacturing and commercialization rights to APL-581 and certain other molecules from Aptose's dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program.</li><li>Aptose retains reacquisition rights to certain molecules while OHM has the rights to develop and sublicense all other molecules.</li><li>Under the terms of the agreement, Aptose will receive a nominal upfront cash payment, up to $125M in milestones and royalties on net sales of commercialized products.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337065\" data-linked=\"Aptose Bio out-licenses APL-581 for up to $125M; shares up 13% premarket\" data-tweet=\"$APTO - Aptose Bio out-licenses APL-581 for up to $125M; shares up 13% premarket https://seekingalpha.com/news/3337065-aptose-bio-out-licenses-aplminus-581-for-up-to-125m-shares-up-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3337065-aptose-bio-out-licenses-aplminus-581-for-up-to-125m-shares-up-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337067\" data-ts=\"1520425873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANF\" target=\"_blank\">ANF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337067-abercrombie-and-amp-fitch-beats-0_28-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abercrombie &amp;amp; Fitch beats by $0.28, beats on revenue</a></h4><ul><li>Abercrombie &amp; Fitch (NYSE:<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a>): Q4 EPS of $1.38 <font color='green'>beats by $0.28</font>.</li><li>Revenue of $1.19B (+14.4% Y/Y) <font color='green'>beats by $30M</font>.</li><li>Shares <font color='green'>+4.22%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17094682-abercrombie-and-fitch-co-reports-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337067\" data-linked=\"Abercrombie &amp;amp; Fitch beats by $0.28, beats on revenue\" data-tweet=\"$ANF - Abercrombie &amp; Fitch beats by $0.28, beats on revenue https://seekingalpha.com/news/3337067-abercrombie-and-amp-fitch-beats-0_28-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337067-abercrombie-and-amp-fitch-beats-0_28-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337066\" data-ts=\"1520425672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESPR\" target=\"_blank\">ESPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337066-esperion-therapeutics-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Esperion Therapeutics shares halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading </a>in Esperion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ESPR' title='Esperion Therapeutics'>ESPR</a>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3337066\" data-linked=\"Esperion Therapeutics shares halted pending news\" data-tweet=\"$ESPR - Esperion Therapeutics shares halted pending news https://seekingalpha.com/news/3337066-esperion-therapeutics-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3337066-esperion-therapeutics-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3337012\" data-ts=\"1520417279\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHM\" target=\"_blank\">ATHM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3337012-autohome-beats-0_31-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autohome beats by $0.31, beats on revenue</a></h4><ul><li>Autohome (NYSE:<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a>): Q4 EPS of $1.00 <font color='green'>beats by $0.31</font>.</li><li>Revenue of $269.2M (-15.2% Y/Y) <font color='green'>beats by $0.57M</font>.</li><li>Shares <font color='green'>+4.4%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17094514-autohome-inc-announces-unaudited-fourth-quarter-full-year-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3337012\" data-linked=\"Autohome beats by $0.31, beats on revenue\" data-tweet=\"$ATHM - Autohome beats by $0.31, beats on revenue https://seekingalpha.com/news/3337012-autohome-beats-0_31-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3337012-autohome-beats-0_31-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 AM </div></div></li>","count":66,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}